Skip to main content

Diabetes Mellitus: Pathophysiology

 PATHOPHYSIOLOGY OF DM

IMPAIRED INSULIN SECRETION

  • A pancreas with normal Beta cell function is able to adjust insulin production to maintain normal blood glucose levels.
  • Hyperinsulinemia or high blood levels of insulin is an early finding of T2 DM.
  • More insulin is secreted to maintain normal blood glucose levels until eventually the pancreas can no longer produce sufficient insulin.
  • Impaired Beta cell function results in reduced ability to produce a first-phase insulin response sufficient to signal the liver to stop producing glucose after a meal.
  • As DM progresses, large numbers of patients with T2DM eventually loses all beta cell function and require exogenous insulin to maintain the blood glucose levels. 


INSULIN RESISTANCE

  • Insulin resistance is the primary factor that differentiates T2DM from other forms of diabetes.
  • Insulin resistance maybe present for several years prior to the diagnosis of DM.
  • Insulin resistance occurs more significantly in skeletal muscles and liver.
  • Insulin resistance in the liver poses a double threat because the liver becomes nonresponsive to insulin for glucose uptake and hepatic production of glucose after a meal does not cease which leads to elevated fasting and post-meal glucose levels.


IMAPIRED GLUCAGON SECRETION

  • Glucagon is the counter regulatory hormones produced by the beta cells that raises blood glucose levels.
  • The release of insulin and the inhibition of glucagon is glucose stimulated.
  • Most patients with a 10–20-year history of T1DM have lost their ability to release glucagon, which increases their risk of hypoglycemic unawareness.



GLUCAGON LIKE PEPTIDE AND GIP IMAPIRED 

People with T2DM have impaired phase 2 insulin release, and some have impaired glucagon-like peptide (GLP-Q) and glucose-dependent insulinotropic polypeptide (GIP) release, which further reduces the release of insulin.

Labels:

Comments

Post a Comment

Popular posts from this blog

Diabetes Mellitus: Clinical Presentation and Diagnosis!

 CLINICAL PRESENTATION AND DIAGNOSIS OF DM 2. SCREENING American Diabetes Association (ADA) recommends routine screening for T2 DM every 3 years in all adults starting at 45 years of age. Testing of T2 DM should be considered in any adult, regardless of their age, who have a BMI greater than or equal to 25kg/m2. The ADA does not currently recommend widespread screening for T1 DM because of the relatively low incidence in the general population, although measurement of Islet antibodies may be appropriate for high-risk individuals. 3.GESTATIONAL DIABETES: "Gestational diabetes is the glucose intolerance in women during pregnancy". All pregnant women who have risk factors for T2 DM should be screened for undiagnosed T2 DM at their first prenatal visit using standard diagnostic criteria.  Any women found to have diabetes in the early point at pregnancy is considered to have T2 DM or GDM. All other pregnant women, not currently known to have DM should be screened for GDM with a 75...
Post a Comment
Read more

Hospital Acquired Pneumonia- Definition, Predisposing Factors, Clinical Features and Management!

 HOSPITAL ACQUIRED PNEUMONIA Definition: "HAP refers to a new episode of pneumonia occurring at least 2 days after the administration to hospital. It is the most common Hospital Acquired Infection (HAI) and leading cause of HAI-associated death". Predisposing factors: Aspiration of nasopharyngeal secretion Bacteria introduced into the lower GIT. Bacteriaemia Old age Mode of Spread:  Droplet infection Infecting agent: Bacteria: S.pneumonia , S.aureus , H.influenza Virus: Adenovirus, Corona virus, Herpes Simplex Clinical Features: Purulent sputum New radiological infiltrates Temperature > 38 degree Celsius Leukocytosis Investigations: Chest Pain:  to confirm the diagnosis and exclude complication. Pulse Oximetry : to monitor response to oxygen therapy, if SaO2 < 93% features of sever pneumonia, identify ventilatory failure or acidosis. Cell count:  ESR, Neutrophil leukocytosis Microbiological studies:  for severe CAP and those that do not respond to ...
Post a Comment
Read more

Management of H.pylori and NSAID-associated ulcers Eradication!

MANAGEMENT FOR H.PYLORI ERADICATION It is known that H.pylori infection is associated with over 90% of duodenal ulcers and 80% of Gastric Ulcers. Antibiotics alone or acid-suppressing agents alone, do not eradicate H.pylori . Both therapies act synergistically as growth of the organism occurs at elevated pH and antibiotics efficacy is enhanced during growth. Additionally, increasing intragastric pH may enhance antibiotic absorption. High eradication rates are achieved by a short course of Triple Therapy consisting of:            1 .PPI                                         2. Clarithromycin                         3. Amoxicillin/Metronidazole          in a twice recommended simultaneous regimen. First-Line Therapy :  European Guidelines recommended 1 we...
Post a Comment
Read more